Arjen M. Dondorp

Jul 29, 2023 | nature.com | Bo Gao |Thu Tran |Arjen M. Dondorp |Maciej F. Boni

AbstractIncreasing levels of artemisinin and partner drug resistance threaten malaria control and elimination globally. Triple artemisinin-based combination therapies (TACTs) which combine artemisinin derivatives with two partner drugs are efficacious and well tolerated in clinical trials, including in areas of multidrug-resistant malaria. Whether early TACT adoption could delay the emergence and spread of antimalarial drug resistance is a question of vital importance.